Remix Therapeutics
  • Our Science
    • Platform
    • Pipeline
  • About Us
    • Our Story
    • Our People
    • Our Investors
    • Our Partners
  • Join Us
  • News
    • News
    • Press Releases
    • Publications
  • Clinical Trials
  • Our Science
    • Platform
    • Pipeline
  • About Us
    • Our Story
    • Our People
    • Our Investors
    • Our Partners
  • Join Us
  • News
    • News
    • Press Releases
    • Publications
  • Clinical Trials
  • Contact

Month: January 2021

First small-molecule drug targeting RNA gains momentum

Posted on January 11, 2021January 13, 2025 by Rachel Suflita McKee

By Cormac Sheridan, Nature Biotechnology

Read More

Posted in News

Recent Posts

  • Watertown biotech on the hunt for capital after early-stage cancer data
  • Remix Therapeutics reveals first signs of tumor shrinkage with its small molecule mRNA degrader
  • Remix Therapeutics™ Announces Positive Preliminary Data from Phase 1 Study of REM-422 in Patients with Adenoid Cystic Carcinoma at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
  • Remix Therapeutics™ to Present Phase 1 Data of REM-422 at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Conference in Late-Breaking Oral Presentation
  • Identification of Selective Small Molecule Modulators of mRNA Processing Using a Multiplexed QuantiGene High-Throughput Screening Platform

Recent Comments

No comments to show.

Archives

  • October 2025
  • August 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • February 2024
  • January 2024
  • December 2023
  • September 2023
  • May 2023
  • March 2023
  • January 2023
  • December 2022
  • September 2022
  • May 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • August 2021
  • March 2021
  • January 2021
  • December 2020

Categories

  • News
  • Press Release
  • Publication
Remix Therapeutics
100 Forge Road
Suite 400
Watertown, USA 02472
781-827-0901
  • Our Science
  • About Us
  • Join Us
  • News
  • Clinical Trials
  • Contact
100 Forge Road
Suite 400
Watertown, USA 02472
781-827-0901
© 2023 Remix Therapeutics, Inc. All Rights Reserved
Privacy Policy
Terms of Use